Variability of ticagrelor antiplatelet responsiveness in Chinese ACS patients

被引：0
|
作者：
Yin, Tong [1 ]
Wang, Xuyun [1 ]
Liu, Jia [1 ]
Chen, Yundai [1 ]
机构：
[1] Chinese Peoples Liberat Army, Gen Hosp, Dept Cardiol, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2015.06.874
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW26-e0691
引用
收藏
页码：C227 / C227
页数：1
相关论文
共 50 条
  • [21] Clopidogrel is a favourable alternative to ticagrelor in older patients with NSTE-ACS
    Huynh, Karina
    NATURE REVIEWS CARDIOLOGY, 2020, 17 (07) : 384 - 384
  • [22] Clopidogrel is a favourable alternative to ticagrelor in older patients with NSTE-ACS
    Karina Huynh
    Nature Reviews Cardiology, 2020, 17 : 384 - 384
  • [23] Benefit of dual antiplatelet therapy overtime with prasugrel or ticagrelor in elderly patients
    Caneiro, B.
    Abu-Assi, E. A. A.
    Raposeiras-Roubin, S. R. R.
    Cobas, R. C. P.
    Munoz, I. M. P.
    Cespon, M. C.
    Rioboo-Leston, L. R. L.
    Jamhour, K. J.
    Fernandez-Barbeira, S. F. B.
    Calvo-Iglesias, F. E. C. I.
    Iniguez-Romo, A. I. R.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1310 - 1310
  • [24] Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes
    Alexopoulos, Dimitrios
    Xanthopoulou, Ioanna
    Mavronasiou, Eleni
    Stavrou, Katerina
    Siapika, Argyro
    Tsoni, Evropi
    Davlouros, Periklis
    DIABETES CARE, 2013, 36 (08) : 2211 - 2216
  • [25] Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients
    Li, Dan-Dan
    Wang, Xu-Yun
    Xi, Shao-Zhi
    Liu, Jia
    Qin, Liu-An
    Jing, Jing
    Yin, Tong
    Chen, Yun-Dai
    JOURNAL OF GERIATRIC CARDIOLOGY, 2016, 13 (04) : 282 - 289
  • [26] Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI The result of the TE-CLOT trial
    Kim, Jeong-Su
    Han, Dong-Cheul
    Jeong, Young-Hoon
    Park, Duk-Woo
    Sohn, Chang-Bae
    Hwang, Ki-Won
    Lee, Sang-Hyun
    Choi, Jin Hee
    Chon, Min-Ku
    Lee, Soo Yong
    Hwang, Jongmin
    Kim, In-Suk
    Lee, Sun-Min
    Han, Junhee
    Noh, Maengseok
    Kim, Chang-Hoon
    Chun, Kook Jin
    Park, Yong Hyun
    Kim, June-Hong
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (01) : 213 - 221
  • [27] Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients
    Dan-Dan LI
    Xu-Yun WANG
    Shao-Zhi XI
    Jia LIU
    Liu-An QIN
    Jing JING
    Tong YIN
    Yun-Dai CHEN
    Journal of Geriatric Cardiology, 2016, 13 (04) : 282 - 289
  • [28] Prasugrel shows less intraday variability in its antiplatelet effect compared to ticagrelor in cynomolgus monkeys
    Tomizawa, A.
    Ohno, K.
    Jakubowski, J. A.
    Mizuno, M.
    Sugidachi, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1146 - 1147
  • [29] Ticagrelor: An emerging oral antiplatelet agent
    Juneja, Shivani
    Gupta, Kanchan
    Kaushal, Sandeep
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (01) : 78 - 80
  • [30] Comparison of the Antiplatelet Effect Between Ticagrelor and Clopidogrel in Chinese Patients with Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention
    Xu, Jingjing
    Yao, Yi
    Zhang, Jiahui
    Tang, Xiaofang
    Ma, Yuanliang
    Yuan, Jinqing
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36
12345